Position in ATAI
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$35,400
-$5,500 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ATAI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Williams Jones Wealth Management, LLC. holds $1,345,606 across 7 Biotechnology names. ATAI ranks #4 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
810 | $625,838 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,135 | $506,822 | |
| 3 | LCTX |
Lineage Cell Therapeutics, Inc.
|
101,300 | $160,054 | |
| 4 | ATAI |
AtaiBeckley Inc.
This page
|
10,000 | $35,400 | |
| 5 | CYDY |
CytoDyn Inc.
|
45,001 | $12,150 | |
| 6 | NWBO |
Northwest Biotherapeutics Inc
|
25,000 | $5,250 | |
| 7 | PKTX |
ProtoKinetix, Inc.
|
20,000 | $92 |
All Filings in ATAI
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $35,400 | 10,000 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $40,900 | 10,000 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||